Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Cell mediated immune responses through TLR4 prevents DMBA-induced mammary carcinogenesis in mice.

Naseemuddin M, Iqbal A, Nasti TH, Ghandhi JL, Kapadia AD, Yusuf N.

Int J Cancer. 2012 Feb 15;130(4):765-74. doi: 10.1002/ijc.26100. Epub 2011 Jun 18.

2.

Protective role of Toll-like receptor 4 during the initiation stage of cutaneous chemical carcinogenesis.

Yusuf N, Nasti TH, Long JA, Naseemuddin M, Lucas AP, Xu H, Elmets CA.

Cancer Res. 2008 Jan 15;68(2):615-22. doi: 10.1158/0008-5472.CAN-07-5219. Erratum in: Cancer Res. 2008 Mar 1;68(5):1609.

3.

Resveratrol enhances cell-mediated immune response to DMBA through TLR4 and prevents DMBA induced cutaneous carcinogenesis.

Yusuf N, Nasti TH, Meleth S, Elmets CA.

Mol Carcinog. 2009 Aug;48(8):713-23. doi: 10.1002/mc.20517.

4.

Antagonistic roles of CD4+ and CD8+ T-cells in 7,12-dimethylbenz(a)anthracene cutaneous carcinogenesis.

Yusuf N, Nasti TH, Katiyar SK, Jacobs MK, Seibert MD, Ginsburg AC, Timares L, Xu H, Elmets CA.

Cancer Res. 2008 May 15;68(10):3924-30. doi: 10.1158/0008-5472.CAN-07-3059.

6.

Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function.

Lydon JP, Ge G, Kittrell FS, Medina D, O'Malley BW.

Cancer Res. 1999 Sep 1;59(17):4276-84.

7.

Overexpression of 5-lipoxygenase and its relation with cell proliferation and angiogenesis in 7,12-dimethylbenz(α)anthracene-induced rat mammary carcinogenesis.

Chatterjee M, Das S, Roy K, Chatterjee M.

Mol Carcinog. 2013 May;52(5):359-69. doi: 10.1002/mc.21858. Epub 2011 Dec 28.

PMID:
22213124
8.

Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.

Benakanakere I, Besch-Williford C, Schnell J, Brandt S, Ellersieck MR, Molinolo A, Hyder SM.

Clin Cancer Res. 2006 Jul 1;12(13):4062-71.

9.

Toll-like receptor 4 is involved in inflammatory and joint destructive pathways in collagen-induced arthritis in DBA1J mice.

Pierer M, Wagner U, Rossol M, Ibrahim S.

PLoS One. 2011;6(8):e23539. doi: 10.1371/journal.pone.0023539. Epub 2011 Aug 17.

10.
11.

PPARgamma influences susceptibility to DMBA-induced mammary, ovarian and skin carcinogenesis.

Nicol CJ, Yoon M, Ward JM, Yamashita M, Fukamachi K, Peters JM, Gonzalez FJ.

Carcinogenesis. 2004 Sep;25(9):1747-55. Epub 2004 Apr 8.

12.

Long-term exposure to elevated levels of circulating TIMP-1 but not mammary TIMP-1 suppresses growth of mammary carcinomas in transgenic mice.

Yamazaki M, Akahane T, Buck T, Yoshiji H, Gomez DE, Schoeffner DJ, Okajima E, Harris SR, Bunce OR, Thorgeirsson SS, Thorgeirsson UP.

Carcinogenesis. 2004 Sep;25(9):1735-46. Epub 2004 May 27.

13.

Loss of PPARγ expression in mammary secretory epithelial cells creates a pro-breast tumorigenic environment.

Apostoli AJ, Skelhorne-Gross GE, Rubino RE, Peterson NT, Di Lena MA, Schneider MM, SenGupta SK, Nicol CJ.

Int J Cancer. 2014 Mar 1;134(5):1055-66. doi: 10.1002/ijc.28432. Epub 2013 Sep 19.

14.

Synthetic progestins differentially promote or prevent 7,12-dimethylbenz(a)anthracene-induced mammary tumors in sprague-dawley rats.

Benakanakere I, Besch-Williford C, Carroll CE, Hyder SM.

Cancer Prev Res (Phila). 2010 Sep;3(9):1157-67. doi: 10.1158/1940-6207.CAPR-10-0064. Epub 2010 Aug 10.

15.

Low TLR4 expression by liver dendritic cells correlates with reduced capacity to activate allogeneic T cells in response to endotoxin.

De Creus A, Abe M, Lau AH, Hackstein H, Raimondi G, Thomson AW.

J Immunol. 2005 Feb 15;174(4):2037-45.

16.

Androgen resistance in female mice increases susceptibility to DMBA-induced mammary tumors.

Simanainen U, Gao YR, Walters KA, Watson G, Desai R, Jimenez M, Handelsman DJ.

Horm Cancer. 2012 Jun;3(3):113-24. doi: 10.1007/s12672-012-0107-9.

PMID:
22370991
17.

Toll-like receptor 4-mediated regulation of spontaneous Helicobacter-dependent colitis in IL-10-deficient mice.

Matharu KS, Mizoguchi E, Cotoner CA, Nguyen DD, Mingle B, Iweala OI, McBee ME, Stefka AT, Prioult G, Haigis KM, Bhan AK, Snapper SB, Murakami H, Schauer DB, Reinecker HC, Mizoguchi A, Nagler CR.

Gastroenterology. 2009 Oct;137(4):1380-90.e1-3. doi: 10.1053/j.gastro.2009.07.004. Epub 2009 Aug 3.

18.

Toll-like receptor-4 signaling mediates hepatic injury and systemic inflammation in hemorrhagic shock.

Prince JM, Levy RM, Yang R, Mollen KP, Fink MP, Vodovotz Y, Billiar TR.

J Am Coll Surg. 2006 Mar;202(3):407-17. Epub 2006 Jan 18.

PMID:
16500244
19.

Inhibition of VEGFR2 prevents DMBA-induced mammary tumor formation.

Heffelfinger SC, Yan M, Gear RB, Schneider J, LaDow K, Warshawsky D.

Lab Invest. 2004 Aug;84(8):989-98.

20.

Toll-like receptor 4 mediates the antitumor host response induced by a 55-kilodalton protein isolated from Aeginetia indica L., a parasitic plant.

Okamoto M, Oh-E G, Oshikawa T, Furuichi S, Tano T, Ahmed SU, Akashi S, Miyake K, Takeuchi O, Akira S, Himeno K, Sato M, Ohkubo S.

Clin Diagn Lab Immunol. 2004 May;11(3):483-95.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk